Lung Cancer
Conference Coverage
Chemo sequencing in elderly adults with NSCLC linked with survival
GENEVA – Which sequences have the best effects, and why might that be?
Conference Coverage
Sex-based differences in lung cancer screening intervals suggested
Prior studies to see whether longer screening intervals were safe have yielded mixed results, possibly because of differences in clinical and...
Conference Coverage
Flu shots may spark immune adverse events in PD-1 blockade for NSCLC
GENEVA – More than half of patients who had received a trivalent influenza vaccine in a small study had immune-related adverse events.
Conference Coverage
VIDEO: Surgery use declines for non–small cell lung cancer
BOSTON – Data show that surgery for early stage non–small cell lung cancer decreased by 12% from 2004 to 2013.
News
FDA approves brigatinib for second-line advanced ALK-positive NSCLC
Approval was based on a meaningful and durable overall response rate in a two-arm, open-label, multicenter trial of 222 patients.
From the Journals
ASCO updates NSCLC guidelines for adjuvant therapy
ASCO presents an update to 2007 guidelines for use of chemotherapy and radiation in NSCLC patients.
Conference Coverage
Nivolumab boosts 5-year survival in advanced NSCLC
Treatment with nivolumab resulted in a 5-year overall survival rate that is much higher than what is reported for this patient population...
News
Osimertinib receives full approval for advanced EGFR-mutated NSCLC
There is a new treatment available for patients who have metastatic epidermal growth factor receptor T790M mutation–positive non–small cell lung...
Conference Coverage
Real-world EGFR and ALK testing of NSCLC falls short
ORLANDO – Tumor-associated mutations go unnoticed surprisingly often.
Opinion
Hold your breath
Doctors have a unique role to play in the fight against air pollution.